Tumor necrosis factor and its potential role in insulin resistance and nonalcoholic fatty liver disease.

Published

Journal Article (Review)

Nonalcoholic fatty liver disease (NAFLD) is a spectrum of hepatic pathology that resembles alcohol-induced fatty liver disease(AFLD), but which develops in individuals who are not heavy drinkers. In people, NAFLD is associated strongly with obesity,insulin resistance, and dysmetabolic syndrome, but the exact mechanisms that promote liver disease in this clinical context remain poorly understood. The proinflammatory cytokine, funor necrosis factor alpha is known to be a key mediator of AFLD. This article discusses clinical and experimental evidence that tumor necrosis factor plays a role in the pathogenesis of insulin resistance syndromes, including nonalcoholic fatty syndromes, including nonalcoholic fatty liver disease.

Full Text

Duke Authors

Cited Authors

  • Diehl, AM

Published Date

  • August 2004

Published In

Volume / Issue

  • 8 / 3

Start / End Page

  • 619 - x

PubMed ID

  • 15331067

Pubmed Central ID

  • 15331067

International Standard Serial Number (ISSN)

  • 1089-3261

Digital Object Identifier (DOI)

  • 10.1016/j.cld.2004.04.012

Language

  • eng

Conference Location

  • United States